| Apalutamide studied in …STUDIED_INderived107 of 107show fewer |
|---|
| → studied in | NCT01946204Phase 3 · active not recruiting A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257736Phase 3 · active not recruiting An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489318Phase 3 · active not recruiting A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662580Phase 1 · active not recruiting ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095089Phase 1 · recruiting A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123758Phase 1 · active not recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02531516Phase 3 · active not recruiting An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592317Phase 1 · active not recruiting A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03523442Phase 1 · active not recruiting A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03767244Phase 3 · active not recruiting A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04325828Phase 2 · active not recruiting A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma · 107 trials list this drug (49 active) | — | — | Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557059Phase 3 · active not recruiting A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05818683Phase 1 · recruiting A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05884398Phase 3 · active not recruiting A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751941Phase 2 · active not recruiting Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07002320Phase 1/Phase 2 · recruiting Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931340Phase 3 · recruiting Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03371719Phase 2 · active not recruiting Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05367440Phase 1/Phase 2 · active not recruiting Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07611110Phase 3 · recruiting AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · 107 trials list this drug (49 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745361Phase 2 · recruiting Study of Oral MRT-2359 With Apalutamide in Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783282Phase 1 · not yet recruiting A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134260Phase 3 · active not recruiting Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05901649completed A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04108208Phase 4 · completed A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06274047Phase 3 · recruiting PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067269Phase 2 · recruiting Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04267887Phase 2 · active not recruiting Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592924Phase 3 · recruiting Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07406282recruiting A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530552Phase 2 · completed Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04947254Phase 2 · recruiting Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422911Phase 2 · recruiting Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. · 107 trials list this drug (49 active) | — | — | Malignant Neoplasm,Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03436654Phase 2 · active not recruiting Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04523207Phase 2 · completed A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02913196Phase 1 · completed Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03821792Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05960578Phase 2 · active not recruiting Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02772588Phase 2 · completed AASUR in High Risk Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03088124Phase 2 · completed Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412396Phase 2 · active not recruiting Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07428642completed PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC. · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360721Phase 2 · terminated Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm,Prostate Adenocarcinoma without Neuroendocrine Differentiation,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03902951Phase 2 · active not recruiting Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534646Phase 2 · recruiting Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 107 trials list this drug (49 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03503344Phase 2 · completed Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009981Phase 3 · completed A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034095completed A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03523338no longer available An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07086651completed A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC) · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03098836Phase 2 · completed Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666129Phase 1 · completed Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05202301completed A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298087Phase 2 · completed Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181203Phase 3 · active not recruiting Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05191680Phase 2 · recruiting TherApeutics in Early ProState Cancer (TAPS02) · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02903368Phase 2 · completed Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013475completed An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World Settings · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04926181Phase 2 · terminated Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer · 107 trials list this drug (49 active) | — | — | Small Cell Neuroendocrine Carcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03903835Phase 3 · recruiting ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01792687Phase 1 · completed Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04421222Phase 1 · terminated Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05295927Phase 1 · terminated A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06758882Phase 2 · recruiting Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366494completed Micro RNAs to Predict Response to Androgen Deprivation Therapy · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03777982Phase 3 · terminated Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05159245Phase 2 · recruiting The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs · 107 trials list this drug (49 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03080116Phase 2 · unknown Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06473259recruiting Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients · 107 trials list this drug (49 active) | — | — | Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06430411not yet recruiting Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141671Phase 2 · unknown Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204302completed An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362149completed An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03311555Phase 2 · completed A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04997252NA · unknown An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05740488NA · unknown Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899077Phase 2 · unknown Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04409288Phase 3 · terminated Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02578797Phase 1 · completed A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study · 107 trials list this drug (49 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106507Phase 1 · completed ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721979Phase 2 · terminated Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717582Phase 2 · not yet recruiting Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02789878Phase 2 · completed Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05406999Phase 2 · recruiting Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03279250Phase 2 · completed Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02770391Phase 2 · completed Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05212857Phase 2 · unknown Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03551782Phase 1 · completed A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02849990Phase 2 · completed A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy · 107 trials list this drug (49 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867020Phase 2 · completed Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585932Phase 2 · withdrawn Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm,Oligometastatic Prostate Carcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04601441Phase 4 · unknown Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan · 107 trials list this drug (49 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173859Phase 2 · withdrawn Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03488810Phase 3 · withdrawn Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02924766Phase 1 · completed A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE) · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162836Phase 1 · completed A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03093272Phase 2 · terminated A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03124433Phase 2 · completed Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01790126Phase 2 · completed The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811809Phase 2 · withdrawn Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03365297Phase 2 · completed Therapeutics in Active Prostate Cancer Surveillance · 107 trials list this drug (49 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02906605Phase 2 · withdrawn A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer · 107 trials list this drug (49 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |